LLS Focuses on Molecular Drivers for Leukemia

Leukemia & Lymphoma Society Initiatives to Halt Early Stage Myeloid Blood Cancers Fourth in ASH 2014 Series by David Wallace PV Reporter sits down with Dr Lee Greenberger, Chief Scientific Officer with LLS, to discuss initiatives to halt early stage myeloid blood cancers (MPNs & MDS).   LLS has grants with Dana Farber to better understand […]

Dr Heinz Gisslinger Enlightens us – Treating MPNs with Interferon for 30 Years

AOP 2014 – The Next Generation Interferon Second in ASH 2014 Series by David Wallace Dr Heinz Gisslinger from Vienna, Austria is a pioneer in treating MPN patients with Interferon (IFN).  PV Reporter sits down with Dr Gisslinger at ASH 2014 to discuss the history of Interferon treatment in MPNs, as well as AOP 2014. […]

error: Content is protected !